Role of Estrogen Receptor-
in the Anterior Pituitary Gland
Kathleen M. Scully,
Anatoli S. Gleiberman,
Jonathan Lindzey,
Dennis B. Lubahn,
Kenneth S. Korach and
Michael G. Rosenfeld
Howard Hughes Medical Institute (K.M.S., A.S.G., M.G.R.),
Department and School of Medicine, University of California, San
Diego, La Jolla, California 92093-0648,
Receptor Biology
Section (J.L., K.S.K.), Laboratory of Reproductive and Developmental
Toxicology, National Institute of Environmental Health Sciences,
Research Triangle Park, North Carolina 27709,
Departments of
Biochemistry and Child Health (D.B.L.), University of Missouri,
Columbia, Missouri 65211
 |
ABSTRACT
|
---|
Targeted insertional disruption of the mouse
estrogen receptor-
(ER
) gene has provided a genetic model in
which to test hypotheses that estrogens exert important effects in
development and homeostatic functions of the anterior pituitary gland,
particularly in the lactotroph and gonadotroph cell types. Analysis of
ER
gene-disrupted mice reveals a marked reduction in PRL mRNA and a
decrease in lactotroph cell number, but normal specification of
lactotroph cell phenotype. Gonadotropin mRNA levels in ER
gene-disrupted female mice are elevated, consistent with previously
described transcriptional suppression of gonadotropin subunit gene
expression in response to sustained administration of estrogen in wild
type mice. These results provide genetic evidence that ER
plays a
critical role in PRL and gonadotropin gene transcription and is
involved in lactotroph cell growth, but is not required for
specification of lactotroph cell phenotype.
 |
INTRODUCTION
|
---|
The five endocrine cell types of the mouse anterior pituitary
gland corticotrophs, gonadotrophs, thyrotrophs, somatotrophs, and
lactotrophs are derived during embryogenesis from a common
primordium, known as Rathkes pouch (1). Differentiation of these cell
types proceeds in a distinct temporal and spatial pattern that is
marked by cell type-specific transcriptional activation of genes
encoding trophic hormones (2). Estrogen receptor (ER) has been detected
as early as embryonic day 17 in the developing mouse pituitary (3),
and, in the adult, relatively high levels of ER mRNA and protein are
expressed in the lactotroph and gonadotroph cell types (4, 5).
In lactotroph cells, estrogens have been proposed to be involved
in specification of cell phenotype, growth, and synthesis and secretion
of PRL. Ontogenic analyses have correlated ER expression with the onset
of PRL gene expression in the embryo and with a postnatal increase in
lactotroph cell number (2, 6, 7, 8). Estrogens have been shown to
stimulate lactotroph cell growth (9, 10) and PRL secretion (11, 12), as
well as having been linked to the development of PRL-secreting
pituitary tumors (13). A number of molecules have been hypothesized to
mediate these effects: vasoactive intestinal peptide (14), galanin
(15), and transforming growth factor-ß3 (16). Additionally, numerous
lines of independent evidence indicate that mature lactotroph cells are
derived from somatotroph cells, possibly through an intermediate cell
type that coexpresses both GH and PRL (17, 18, 19, 20, 21, 22, 23, 24).
Ligand-bound ER has been demonstrated to activate PRL
transcription via direct interaction with the PRL gene distal enhancer
(25, 26, 27). Treatment with estrogen results in increased nuclease
hypersensitivity of the PRL promoter and increased interaction of the
promoter with the PRL distal enhancer (28, 29, 30). Transcriptional
activation of PRL gene expression by ER involves synergism with the
pituitary-specific POU domain factor, Pit-1, bound to a monomer DNA
recognition site that dictates use of a tyrosine-dependent synergy
domain in Pit-1 (2, 31, 32, 33).
Regulation of gonadotropin synthesis and secretion is mediated by
GnRH from the hypothalamus, gonadal peptides, and classical feedback
effects by gonadal steroids (34). Although an estrogen surge during
proestrus can directly induce transcription of LHß mRNA (35), chronic
treatment of animals with estrogens results in suppression of
expression of all three gonadotropin subunit genes LHß, FSHß,
and
-glycoprotein subunit (
GSU) (36). The majority of evidence
suggests that suppression of gonadotropin synthesis by chronic estrogen
treatment is mediated indirectly via decreased hypothalamic GnRH
secretion or altered pituitary responsiveness to GnRH (37, 38, 39, 40, 41, 42, 43, 44).
However, the level at which estrogens regulate gonadotropin synthesis
is species-dependent. In the rat, gonadotropin synthesis in isolated
pituitaries in culture shows no response to estrogen while GnRH mRNA
levels in cultured hypothalamic explants decrease in response to
estrogen (34). In sheep, in contrast, estrogen has been shown to
suppress FSHß subunit transcription in isolated pituitary cell
cultures (45).
The ER
gene-disrupted mouse has provided a genetic model in
which to test hypotheses regarding the role of estrogens in the
development and function of the anterior pituitary (46). The ER
gene-disrupted mice undergo normal prenatal sexual development and
survive to adulthood, but both genders are completely infertile. Mutant
females possess hypoplastic uteri and hyperemic ovaries with no
detectable corpora lutea (46), have circulating estradiol levels that
are 10-fold higher than wild type females (47), and exhibit alteration
of gender-specific behaviors (48). Mutant males possess small testis,
dysmorphogenic seminiferous tubules, and low sperm count (49). In this
report, we examine the effect of a targeted insertional disruption of
the mouse ER
gene on differentiation of endocrine cell types and
trophic hormone gene expression in the anterior pituitary gland.
 |
RESULTS
|
---|
Trophic Hormone mRNA Levels in ER
Gene-Disrupted and Wild Type
Female Mice
To assess the effect of ER
gene disruption on the
expression of genes encoding markers of terminal differentiation,
Northern analysis was used to compare steady state levels of mRNAs
encoding all of the anterior pituitary trophic hormones in wild type
and ER
gene-disrupted mice (Fig. 1
). Total RNA was
isolated from pooled pituitaries of wild type and ER
gene-disrupted
4-month-old non-parous female mice.
The change in the level of PRL transcripts was the most dramatic,
revealing a nearly 20-fold decrease in the ER
gene-disrupted mice
relative to wild type controls, providing genetic evidence in support
of a positive role for ER
in activation of PRL gene expression
(25, 26, 27, 28, 29, 30, 31, 32, 33). Transcripts encoding all of the gonadotropin subunits were
increased in the ER
gene-disrupted mice relative to wild type
controls. Messenger RNA levels of the common
GSU subunit increased
4-fold in the ER
gene-disrupted mice, while transcripts encoding the
unique subunits of the gonadotropins, LHß and FSHß, both increased
almost 7-fold. This outcome is in agreement with data obtained in
numerous studies using gonadectomy and estrogen replacement in which
removal of the ovaries resulted in increased expression of all three
gonadotropin subunit mRNAs, and subsequent administration of estrogen
coordinately suppressed gonadotropin mRNA levels (50). Levels of POMC,
TSHß, and GH mRNAs all increased to a small degree in the ER
gene-disrupted mice relative to wild type mice, although it is
difficult to ascribe biological significance to these results.
Comparison of Gonadotropin and PRL mRNA Levels in ER
Gene-Disrupted and Ovariectomized Wild Type Mice to Intact Wild Type
Mice
To evaluate the difference in the effect on anterior pituitary
trophic hormone gene expression that resulted from hereditary ER
gene disruption vs. acute loss of estrogenic ligands,
changes in steady state levels of mRNAs encoding the trophic hormones
LHß, FSHß, and PRL from ER
gene-disrupted mice were compared by
Northern analysis to the changes in mRNA levels that occurred in wild
type mice of the same age and gender that had been ovariectomized 10 to
14 days before death (Fig. 2
). In both
the ER
gene-disrupted and the ovariectomized wild type mice, LHß
and FSHß mRNAs increased to approximately equivalent levels compared
to intact wild type mice. These data indicated that a transient
decrease in estrogen produced by removal of the main site of estrogen
synthesis, the ovaries, had essentially the same effect on the levels
of LHß and FSHß mRNAs as hereditary ER
gene disruption. In the
case of PRL transcripts, however, the decrease in steady state
transcript level in the ovariectomized mice, approximately 2-fold, was
not as large as the decrease seen in the ER
gene-disrupted mice,
which was more than 10-fold. This result suggested that for PRL gene
expression, the effect of hereditary ER
gene disruption was more
profound than acute loss of estrogenic ligands.
PRL mRNA Levels in ER
Gene-Disrupted and Wild Type Male Mice
The first case of a mutation in the human ER, a single base pair
change in the second exon that generated a premature stop codon, was
recently reported in a 28-yr-old male (51). Biochemical measurement of
serum levels of anterior pituitary hormones in this patient revealed
significantly increased levels of LH and FSH, but PRL serum
concentrations in the normal range. Although posttranscriptional
regulation might have compensated for a decrease in PRL mRNA in the
human male, it was of interest to examine male ER
gene-disrupted
mice to identify a possible gender difference in the requirement for
ER
in generation of normal PRL mRNA levels. Northern analysis was
used to compare the steady state level of PRL mRNA in ER
gene-disrupted mice and wild type control mice (Fig. 3
). As in the case
of the female ER
gene-disrupted mice, however, there was a large
decrease of approximately 10-fold in the PRL mRNA levels of male ER
gene-disrupted mice.
Immunohistochemical Comparison of Trophic Hormones in the Anterior
Pituitaries of Wild Type and ER
Gene-Disrupted Mice
To assess the effect of ER
gene disruption on growth of
specific cell types and secretion of trophic hormones, pituitary glands
of wild type and ER
gene-disrupted adult female mice were sectioned
and immunostained with antisera directed against the trophic hormones
elaborated by each of the five endocrine cell types. The patterns of
immunostaining of all three gonadotropin subunit proteins (
GSU,
LHß, and FSHß) were altered in the ER
gene-disrupted mice
relative to wild type controls (Fig. 4A
). Immunostaining of
GSU, the
common subunit of LH, FSH, and TSH, revealed a moderate increase in
cell density in the ER
gene-disrupted mice relative to wild type
control mice. An increase in cell density was also noted in the ER
gene-disrupted mice with TSHß immunostaining, but no change was
observed with LHß or FSHß immunostaining. In the case of LHß, the
intensity of cytoplasmic staining in the ER
gene-disrupted mice was
significantly decreased relative to wild type mice, suggesting that
ER
may normally exert a suppressive effect on LH secretion. FSHß
immunostaining in the ER
gene-disrupted mice was similar to the wild
type mice with the exception of a small number of cells in the ER
gene-disrupted mice that displayed increased intensity of cytoplasmic
staining.

View larger version (138K):
[in this window]
[in a new window]
|
Figure 4. Immunohistochemical Staining of Trophic Hormones in
ER Gene-Disrupted (ER-/-) and Wild-Type (ER+/+) Mice
Coronal sections from adult female ER gene-disrupted (n = 3)
and wild type (n = 3) mice were immunostained with primary antisera
directed against pituitary trophic hormones. Secondary antibodies were
coupled to horseradish peroxidase. Sections were reacted with peroxide
and diaminobenzidine as the chromogen and counter stained with methyl
green. A, Gonadotropin subunit immunostaining. B, ACTH, TSHß, GH, and
PRL immunostaining.
|
|
PRL immunostaining revealed a modest decrease in lactotroph cell
density, suggesting that, in agreement with existing data, ER
normally exerts a positive effect on lactotroph cell growth (Fig. 4B
).
Among immunoreactive PRL cells, however, no difference in intensity of
cytoplasmic staining was observed between ER
gene-disrupted and wild
type mice. Immunostaining with antisera directed against ACTH revealed
a moderate increase in cell density in ER
gene-disrupted mice
relative to wild type controls, but no change was detected with GH
antisera.
Lactotroph Cell Phenotype Specification in ER
Gene-Disrupted
Mice
Although it has been hypothesized that lactotrophs are derived
from somatotrophs, possibly through an intermediate somatolactotroph
cell type that coexpresses GH and PRL (17, 18, 19, 20, 21, 22, 23, 24), transcription factors
involved in switching trophic hormone gene expression from GH to PRL
have not been conclusively identified. ER is a candidate factor for
such a role because its ontogeny parallels the ontogeny of PRL
expression (6, 7, 8), and because ER positively regulates PRL
transcription (25, 26, 27, 28, 29, 30, 31, 32, 33). If ER
functioned in such a capacity, mice
harboring an ER
gene disruption might lack mature lactotrophs that
express only PRL and not GH. To assess the effect of ER
gene
disruption on progression of the somatotroph-lactotroph lineage,
pituitary sections from adult ER
gene-disrupted female mice were
simultaneously immunostained with antisera directed against both GH and
PRL. Results were visualized using dual indirect immunofluorescence
(Fig. 5
). Specification of lactotroph cell phenotype appeared to be
unaffected in the ER
gene-disrupted mice based on the readily
observable immunostaining of numerous cells that express PRL but do not
coexpress GH.

View larger version (54K):
[in this window]
[in a new window]
|
Figure 5. Immunohistochemical Analysis of the
Somatotroph-Lactotroph Cell Lineage in ER Gene-Disrupted (ER-/-)
Mice
Double labeling of coronal sections from adult female ER
gene-disrupted (ER-/-) mice (n = 3) with primary antisera
directed against GH and PRL. Secondary antibody directed against the GH
antisera was labeled with rhodamine (red) and against
the PRL antisera with fluorescein (green).
Arrowheads indicate cells that labeled with PRL but not
GH antisera.
|
|
 |
DISCUSSION
|
---|
Analysis of trophic hormone gene expression in ER
gene-disrupted mice provides genetic evidence for the long-held
hypothesis that a major effect of estrogen in the anterior pituitary
gland is to increase PRL gene expression (25, 26, 27, 28, 29, 30, 31, 32, 33). This may result from
a direct effect on PRL gene transcription and an effect on lactotroph
cell growth. Comparison of PRL mRNA levels in ER
gene-disrupted and
ovariectomized wild type mice to intact wild type mice revealed a
greater decrease in PRL mRNA level in the ER
gene-disrupted mice
than in ovariectomized wild type mice, suggesting that ER
gene
disruption results in a more profound effect on PRL gene expression
than acute loss of estrogenic ligands. In support of a role for
estrogens in lactotroph cell growth (6, 7, 8, 9, 10), immunohistochemical
staining of the pituitary glands of ER
gene-disrupted mice with PRL
antisera revealed a modest decrease in lactotroph cell density. Despite
the decrease in PRL mRNA, there was no discernable decrease in
cytoplasmic PRL immunoreactivity in individual lactotroph cells in
sections from ER
gene-disrupted mice, in support of a role for ER
in estrogen-stimulated secretion of PRL. The overall decrease in the
size of the anterior pituitary gland noted in the ER
gene-disrupted
mice may result from decreased lactotroph cell number and may, in turn,
explain the apparent relative increase in density of the ACTH-,
GSU-, and TSHß-positive cells.
Another potential role for estrogens in the anterior pituitary was
specification of lactotroph cell phenotype (8). Several lines of
independent evidence indicate that the GH-producing somatotrophs and
the PRL-producing lactotrophs are lineally related, with somatotrophs
giving rise to mature lactotrophs (17, 18, 19, 20, 21, 22, 23, 24, 52). Additionally, because
of the parallel ontogeny of ER and PRL gene expression (2), and the
positive effect of estrogen on PRL gene transcription (25, 26, 27, 28, 29, 30, 31, 32, 33) and
lactotroph cell growth (6, 7, 8, 9, 10), it was of interest to examine the
effect of ER
gene disruption on progression of the
somatotroph-lactotroph lineage. Dual indirect immunofluorescence
experiments with antisera directed against GH and PRL revealed a large
number of cells staining for PRL, but not GH, in the ER
gene-disrupted mice, indicating that ER
is not required for
specification of lactotroph cell phenotype as the
somatotroph-lactotroph lineage progresses.
Increased gonadotropin hormone mRNA levels in ER
gene-disrupted mice
have provided support for previous findings indicating that estrogens
suppress synthesis of
GSU, LHß, and FSHß subunit mRNAs (36, 37, 38, 39, 40, 41, 42, 43, 44).
Furthermore, when compared to wild type mice, an increase of similar
magnitude in LHß and FSHß mRNA levels was observed in ER
gene-disrupted and ovariectomized wild type mice, suggesting that ER
gene disruption produced the same result as acute loss of estrogenic
ligands. Immunohistochemical staining of the anterior pituitaries of
ER
gene-disrupted mice with LHß and FSHß antisera revealed no
change in gonadotroph cell density, but did show a notable decrease in
LHß cytoplasmic immunoreactivity, compatible with a possible
posttranscriptional role for ER
.
ER
gene-disrupted mice are a valuable model for the study of
estrogen insensitivity in the anterior pituitary gland, as demonstrated
by the profound effects on PRL and gonadotropin gene expression
documented in the ER
gene-disrupted mice. The more modest effect on
lactotroph cell growth observed in the ER
gene-disrupted mice could
reflect limited biological dependence of lactotroph cell growth on
ER
, expression of variant ER
transcripts in the ER
gene-disrupted mice, or a possible role for the recently discovered
novel ER, ERß (53, 54, 55). ERß mRNA was not detected, however, by
RNase protection assay of pituitaries from either wild type or ER
gene-disrupted mice, diminishing the likelihood that ERß mediates
estrogen effects in the pituitary (J. Couse and K. Korach, unpublished
data). RNase protection assays with a probe to the ligand-binding
domain of ER
, in contrast, detected 1020% of wild type levels of
ER
mRNA in pituitaries from ER
gene-disrupted mice (J. Couse and
K. Korach, unpublished data). It has not been proven whether this ER
mRNA represents a variant transcript, such as the E1 transcript
identified in the uterus of ER
gene-disrupted mice (47), or the
estrogen-inducible female- and tissue-specific transcripts reported in
the pituitary of the rat (56). In the uterus of the ER
gene-disrupted mice, however, despite the presence of low levels of the
E1 variant transcript, there was no increase of known uterine markers
of estrogen action in response to treatment with estrogen, indicating
that the presence of the E1 transcript did not result in any
biologically significant response to estrogen in this organ (47). In
the pituitary, given the pronounced effect of ER
gene disruption on
PRL and gonadotropin gene expression, it seems likely that the more
modest effect on lactotroph cell density may reflect a limited
requirement for ER
in normal lactotroph cell growth.
In summary, these genetic data argue that the major effects of ER
in
the anterior pituitary gland are in regulation of PRL and gonadotropin
gene expression. The data also suggest a limited role for ER
in
lactotroph cell growth and possible involvement of ER
in PRL and LH
secretion, but no requirement for ER
in specification of the
lactotroph cell phenotype.
 |
MATERIALS AND METHODS
|
---|
Northern Blot Analysis
Total RNA was isolated by the acid-phenol method from
pituitaries of 4-month-old female (male, Fig. 3
) mice. Pituitaries were
excised and frozen on dry ice, then lysed in Solution D (4
M guanidine isothiocyanate, 25 mM sodium
citrate, pH 7.0, 0.5% sarcosyl, and 0.1 M
2-mercaptoethanol) in a volume of 0.5 ml per pituitary. Sodium acetate,
pH 4.0, was added to 0.2 M final concentration, and the
mixture was extracted with an equal volume of water-saturated phenol
and 0.2 volume of chloroform. The aqueous phase was precipitated with
an equal volume of isopropanol, resuspended in 15% of the original
volume of Solution D, and precipitated again with an equal volume of
isopropanol. The precipitate was washed twice with 75% ethanol and
resuspended in water. The RNA was size fractionated on 1.1%
formaldehyde/1.2% agarose gels, transferred to nylon membranes, and
hybridized overnight at 65 C to DNA probes random-primed-labeled with
Klenow fragment and 32P to a specific activity of
109 cpm/µg. The membranes were washed in
0.3XxNaCl-sodium citrate (SSC) for 45 min at 65 C and exposed to x-ray
film. After x-ray film development, the blots were stripped and
rehybridized with a 32P-labeled ß-actin DNA probe. For
quantification, phosphor screens were exposed to the blots, and the
imaged signals for trophic hormone mRNAs were normalized to the
ß-actin signal.
Immunohistochemical Analysis
Mice were perfused transcardially with 20 ml PBS followed
by 30 ml 10% formalin. Pituitaries were excised, postfixed in
ethanol-37% formaldehyde-H20 water (6:1:3) for 1 h at
room temperature, washed three times in 70% ethanol, and stored in
70% ethanol at 4 C. Pituitaries were dehydrated in isopropanol and
toluene and embedded in paraffin. Five-micrometer thick sections were
cut, mounted, and rehydrated in toluene and ethanol. All further steps
were carried out in a solution of PBS and 0.05% TritonX-100. Sections
were blocked with 10% normal goat serum and immunostained with
polyclonal antisera for 1 h at room temperature. Antisera from the
National Hormone and Pituitary Program (NIDDK, Rockville, MD) were
directed against rat TSHß (AFP-1274789) used at a dilution of
1:10,000, rat LHß (AFP-2223879OGPOLHB) used at 1:12,500, and human
FSHß (AFP-891891) used at 1:250. Antiserum against human ACTH (Sigma
Chemical Co., St. Louis, MO) was used at 1:1000. Antisera against human
GH and human PRL (DAKO, Santa Barbara, CA) were used at 1:200.
Secondary antibodies coupled to horseradish peroxidase and directed
against guinea pig (DAKO) or rabbit (Amersham, Arlington Heights, IL)
were used at 1:100. Diaminobenzidine was the chromogen supplied as a
diaminobenzidine/metal concentrate mixed with stable peroxidase
substrate buffer (Pierce, Rockford, IL). Sections were counterstained
with methyl green. All comparative immunostaining data are derived from
ER
gene-disrupted and wild type mouse pituitary sections mounted on
the same slides to ensure uniformity of processing.
Antisera directed against rat GH from the National Hormone and
Pituitary Program (AFP 411S) was used at a dilution of 1:3000 and
detected with secondary antibody coupled to rhodamine (Cappel, Durham,
NC) used at 1:200. Antisera directed against human PRL (Vector,
Burlingame, CA) was used at a dilution of 1:250 and detected with
secondary antibody coupled to fluorescein (American Qualex, San
Clemente, CA) used at 1:100.
 |
ACKNOWLEDGMENTS
|
---|
We gratefully acknowledge Dr. Aimee Ryan, Dr. Bogi Andersen, and
Daniel Szeto for critical reading and constructive comments during
preparation of this manuscript. We also thank the National Hormone and
Pituitary Program, NIDDK (Rockville, MD), and Dr. A. F. Parlow for
generously providing antisera to anterior pituitary trophic
hormones.
 |
FOOTNOTES
|
---|
Address requests for reprints to: Michael G. Rosenfeld, University of California, San Diego, CMM-West Room 353, 9500 Gilman Drive, La Jolla, California 92093-0648.
Received for publication February 26, 1997.
Accepted for publication March 24, 1997.
 |
REFERENCES
|
---|
-
Schwind JL 1928 The development of the hypophysis cerebri
of the albino rat. Am J Anat 41:295319
-
Simmons DM, Voss JW, Ingraham HA, Holloway JM, Broide RS,
Rosenfeld MG, Swanson LW 1990 Pituitary cell phenotypes involve
cell-specific Pit-1 mRNA translation and synergistic interactions with
other classes of transcription factors. Genes Dev 4:695711[Abstract]
-
Keefer D, Holderegger C 1985 The ontogeny of estrogen
receptors: brain and pituitary. Brain Res 351:129142[Medline]
-
Friend KE, Chiou YK, Lopes MB, Laws ER Jr, Hughes KM, Shupnik
MA 1994 Estrogen receptor expression in human pituitary: correlation
with immunohistochemistry in normal tissue, and immunohistochemistry
and morphology in macroadenomas. J Clin Endocrinol Metab 78:14971504[Abstract]
-
Stefaneanu L, Kovacs K, Horvath E, Lloyd RV, Buchfelder M,
Fahlbusch R, Smyth H 1994 In situ hybridization study of
estrogen receptor messenger ribonucleic acid in human adenohypophysial
cells and pituitary adenomas. J Clin Endocrinol Metab 78:8378[Abstract]
-
Gash D, Ahmad N, Weiner R, Schechter J 1980 Development of
presumptive mammotrophs in isografts is dependent on the endocrine
state of the host. Endocrinology 106:12461252[Medline]
-
Staubaugh MB, Lieberman ME, Rutledge JJ, Gorski J 1982 Ontogeny of growth hormone and PRL gene expression in mice.
Endocrinology 110:14891497[Medline]
-
Lieberman ME, Slabaugh MB, Rutledge JJ, Gorski, J 1983 The
role of estrogen in the differentiation of PRL producing cells. J
Steroid Biochem 19:275281[Medline]
-
Amara JF, Van Itallie C, Dannies PS 1987 Regulation of
prolactin production and cell growth by estradiol: difference in
sensitivity to estradiol occurs at level of messenger ribonucleic acid
accumulation. Endocrinology 120:264271[Abstract]
-
Wiklund J, Rutledge J, Gorski J 1981 A genetic model for the
inheritance of pituitary tumor susceptibility in F344 rats.
Endocrinology 109:17081714[Abstract]
-
Raymond V, Beaulieu M, Labrie F, Boissier J 1978 Potent
antidopaminergic activity of estradiol at the pituitary level on PRL
release. Science 200:11731175[Medline]
-
Chen CL, Amenomori Y, Lu KH, Voogt J, Meites J 1970 Serum PRL
levels in rats with pituitary transplants or hypothalamic lesions.
Neuroendocrinology 6:220227[Medline]
-
Wendell DL, Herman A, Gorski J 1996 Genetic separation of
tumor growth and hemorrhagic phenotypes in an estrogen-induced
tumor. Proc Natl Acad Sci USA 93:81128116[Abstract/Free Full Text]
-
Prysor-Jones RA, Silverlight JJ, Kennedy SJ, Jenkins JS 1988 Vasoactive intestinal peptide and the stimulation of lactotroph growth
by oestradiol in rats. J Endocrinol 116:259265[Abstract]
-
Wynick D, Hammond PJ, Akinsanya KO, Bloom SR 1993 Galanin
regulates basal and oestrogen-stimulated lactotroph function. Nature 364:529532[CrossRef][Medline]
-
Burns G, Sarkar DK 1993 Transforming growth factor ß 1-like
immunoreactivity in the pituitary gland of the rat: effect of estrogen.
Endocrinology 133:14441449[Abstract]
-
Hoeffler JP, Boockfor FR, Frawley LS 1985 Ontogeny of PRL
cells in neonatal rats: initial PRL secretors also release growth
hormone. Endocrinology 117:187195[Abstract]
-
Nelson C, Albert VR, Elsholtz HP, Lu LI, Rosenfeld MG 1988 Activation of cell-specific expression of rat growth hormone and PRL
genes by a common transcription factor. Science 239:14001405[Medline]
-
Ingraham HA, Chen R, Mangalam HJ, Elsholtz HP, Flynn SE, Lin
CR, Simmons DM, Swanson L, Rosenfeld MG 1988 A tissue-specific
transcription factor containing a homeodomain specifies a pituitary
phenotype. Cell 55:519529[Medline]
-
Mangalam HJ, Albert VR, Ingraham HA, Kapiloff M, Wilson L,
Nelson C, Elsholtz H, Rosenfeld MG 1989 A pituitary POU domain protein,
Pit-1, activates both growth hormone and PRL promoters
transcriptionally. Genes Dev 3:946958[Abstract]
-
Fox SR, Jong MTC, Casanova J, Ye SF, Stanley F, Samuels HH 1990 The homeodomain protein, Pit-1/GHF1, is capable of binding to and
activating cell-specific elements of both the growth hormone and PRL
gene promoters. Mol Endocrinol 4:10691080[Abstract]
-
Li S, Crenshaw EB, Rawson EJ, Simmons DM, Swanson LW,
Rosenfeld MG 1990 Dwarf locus mutants lacking three pituitary cell
types result from mutations in the POU-domain gene pit-1.
Nature 347:528533[CrossRef][Medline]
-
Behringer RR, Mathews LS, Palmiter RD, Brinster RL 1988 Dwarf
mice produced by genetic ablation of growth hormone-expressing cells.
Genes Dev 2:453461[Abstract]
-
Borrelli E, Heyman RA, Arias C, Sawchenko PE, Evans RM 1989 Transgenic mice with inducible dwarfism. Nature 339:538541[CrossRef][Medline]
-
Maurer RA, Notides AC 1987 Identification of an
estrogen-responsive element from the 5'-flanking region of the rat PRL
gene. Mol Cell Biol 7:42474254[Medline]
-
Waterman ML, Adler SR, Nelson CA, Greene GL, Evans RM,
Rosenfeld MG 1988 A single domain of the estrogen receptor confers DNA
binding and transcriptional activation of the rat PRL gene. Mol
Endocrinol 2:1421[Abstract]
-
Murdoch FE, Byrne LM, Ariazi EA, Furlow JD, Meier DA, Gorski J 1995 Estrogen receptor binding to DNA: Affinity for nonpalindromic
elements from the rat PRL gene. Biochemistry 34:91449150[Medline]
-
Seyfred MA, Gorski J 1990 An interaction between the 5'
flanking distal and proximal regulatory domains of the rat PRL gene is
required for transcriptional activation by estrogens. Mol Endocrinol 4:12261234[Abstract]
-
Cullen KE, Kladde MP, Seyfred MA 1993 Interaction between
transcription regulatory regions of PRL chromatin. Science 261:203206[Medline]
-
Gothard LQ, Hibbard JC, Seyfred MA 1996 Estrogen-mediated
induction of rat prolactin gene transcription requires the formation of
a chromatin loop between the distal enhancer and proximal promoter
regions. Mol Endocrinol 10:185195[Abstract]
-
Day RN, Koike S, Sakai M, Muramatsu M, Maurer RA 1990 Both
Pit-1 and the estrogen receptor are required for estrogen
responsiveness of the rat PRL gene. Mol Endocrinol 4:19641971[Abstract]
-
Nowakowski BE, Maurer RA 1994 Multiple Pit-1-binding sites
facilitate estrogen responsiveness of the PRL gene. Mol Endocrinol 8:17421749[Abstract]
-
Holloway JM, Szeto DP, Scully KM, Glass CK, Rosenfeld MG 1995 Pit-1 binding to specific DNA sites as a monomer or dimer determines
gene-specific use of a tyrosine-dependent synergy domain. Genes Dev 9:19922006[Abstract]
-
Gharib SD, Wierman ME, Shupnik MA, Chin WW 1990 Molecular
biology of the pituitary gonadotropins. Endocr Rev 11:177199[Medline]
-
Shupnik MA, Rosenzweig BA 1991 Identification of an
estrogen-responsive element in the rat LHß gene. J Biol Chem 266:1708417091[Abstract/Free Full Text]
-
Shupnik MA, Gharib SD, Chin WW 1988 Estrogen suppresses rat
gonadotropin gene transcription in vivo. Endocrinology 122:18421846[Abstract]
-
Keri RA, Andersen B, Kennedy GC, Hamernik DL, Clay CM, Brace
AD, Nett TM, Notides AC, Nilson JH 1991 Estradiol inhibits
transcription of the human glycoprotein hormone
-subunit gene
despite the absence of a high affinity binding site for estrogen
receptor. Mol Endocrinol 5:725733[Abstract]
-
Keri RA, Wolfe MW, Saunders TL, Anderson I, Kendall SK, Wagner
T, Yeung J, Gorski J, Nett TM, Camper SA, et al. 1994 The proximal
promoter of the bovine luteinizing hormone ß-subunit gene confers
gonadotrope-specific expression and regulation by
gonadotropin-releasing hormone, testosterone, and 17ß-estradiol
in transgenic mice. Mol Endocrinol 8:18071816[Abstract]
-
Quiñones-Jenab V, Jenab S, Ogawa S, Funabashi T, Weesner
GD, Pfaff DW 1996 Estrogen regulation of gonadotropin-releasing hormone
receptor messenger RNA in female rat pituitary tissue. Mol Brain Res 38:243250[Medline]
-
Kaiser UB, Jakubowiak A, Steinber A, Chin WW 1993 Regulation
of rat pituitary gonadotropin-releasing hormone receptor mRNA levels
in vivo and in vitro. Endocrinology 133:931934[Abstract]
-
Kakar SS, Grantham K, Musgrove LC, Devor D, Sellers JC, Neill
JD 1994 Rat gonadotropin-releasing hormone (GnRH) receptor: tissue
expression and hormonal regulation of its mRNA. Mol Cell Endocrinol 101:151157[CrossRef][Medline]
-
McArdle CA, Schomerus E, Gröner I, Poch A 1992 Estradiol
regulates gonadotropin-releasing hormone receptor number, growth and
inositol phosphate production in
T31 cells. Mol Cell Endocrinol 87:95103[CrossRef][Medline]
-
Bauer-Dantoin AC, Weiss J, Jameson JL 1995 Roles of estrogen,
progesterone, and gonadotropin-releasing hormone (GnRH) in the control
of pituitary GnRH receptor gene expression at the time of the
preovulatory gonadotropin surges. Endocrinology 136:10141019[Abstract]
-
Kaiser UB, Jakubowiak A, Steinberger A, Chin WW 1993 Regulation of rat pituitary gonadotropin-releasing hormone receptor
mRNA levels in vivo and in vitro. Endocrinology 133:931934[Abstract]
-
Alexander DC, Miller WL 1982 Regulation of ovine
follicle-stimulating hormone ß-chain by 17ß-estradiol in
vivo and in vitro. J Biol Chem 257:22822286[Free Full Text]
-
Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies
O 1993 Alteration of reproductive function but not prenatal sexual
development after insertional disruption of the mouse estrogen receptor
gene. Proc Natl Acad Sci USA 90:1116211166[Abstract]
-
Couse JF, Curtis SW, Washburn TF, Lindzey J, Golding TS,
Lubahn DB, Smithies O, Korach, KS 1995 Analysis of transcription and
estrogen insensitivity in the female mouse after targeted disruption of
the estrogen receptor gene. Mol Endocrinol 9:14411454[Abstract]
-
Ogawa S, Taylor JA, Lubahn DB, Korach KS, Pfaff DW 1996 Reversal of sex roles in genetic female mice by disruption of estrogen
receptor gene. Neuroendocrinology 64:467470[Medline]
-
Eddy EM, Washburn TF, Bunch DO, Goulding EH, Gladen BC, Lubahn
DB, Korach KS 1996 Targeted disruption of the estrogen receptor gene in
male mice causes alteration of spermatogenesis and infertility.
Endocrinology 137:4796805[Abstract]
-
Shupnik MA 1996 Gonadotropin gene modulation by steroids and
gonadotropin-releasing hormone. Biol Reprod 54:279286[Abstract]
-
Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B,
Williams TC, Lubahn DB, Korach KS 1994 Estrogen resistance caused by a
mutation in the estrogen-receptor gene in a man. N Engl J Med 331:10561061[Abstract/Free Full Text]
-
Stratmann IE, Ezrin C, Sellers EA 1974 Estrogen-induced
transformation of somatotrophs into mammotrophs in the rat. Cell Tissue
Res 152:229238[Medline]
-
Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson
J-A 1996 Cloning of a novel estrogen receptor expressed in rat prostate
and ovary. Proc Natl Acad Sci USA 93:59255930[Abstract/Free Full Text]
-
Mosselman S, Polman J, Dijkema R 1996 ERß: identification
and characterization of a novel human estrogen receptor. FEBS Lett 392:4953[CrossRef][Medline]
-
Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA,
Labrie F, Giguere V 1997 Cloning, chromosomal localization, and
functional analysis of the mouse estrogen receptor ß. Mol Endocrinol 11:353365[Abstract/Free Full Text]
-
Friend KE, Ang LW, Shupnik MA 1995 Estrogen regulates the
expression of several different estrogen receptor mRNA isoforms in rat
pituitary. Proc Natl Acad Sci USA 92:43674371[Abstract]